HomeProductsBioactive CompoundsMetabolic EnzymesAldose ReductaseAlrestatin
Chemical structure of CAS 51411-04-2

Alrestatin

In Stock•Starting at $120 for 100 mg•Purity ≥ 98%
CAS No.51411-04-2
MDL No.MFCD00181399
MFC14H9NO4
MW255.22
InChI KeyGCUCIFQCGJIRNT-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg98+%$120In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.51411-04-2
Product NameAlrestatin
IrritantIrritant
Signal Word:Warning
HCode:H302-H315-H319-H335
PCode:P261-P264-P264+P265-P270-P271-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions.

Frontiers in pharmacology • Vol. 3 • 2012
PMID: 22654757PMC: PMC3360414DOI: 10.3389/fphar.2012.00098

Copper(II) carboxylate dimers prepared from ligands designed to form a robust π···π stacking synthon: supramolecular structures and molecular properties.

Inorganic chemistry • Vol. 51, Issue 2 • 2012
PMID: 22220674DOI: 10.1021/ic202198k

Diabetic cataract-pathogenesis, epidemiology and treatment.

Journal of ophthalmology • Vol. 2010 • 2010
PMID: 20634936PMC: PMC2903955DOI: 10.1155/2010/608751

Advances in pharmacological strategies for the prevention of cataract development.

Indian journal of ophthalmology • Vol. 57, Issue 3 • 2009
PMID: 19384010PMC: PMC2683438DOI: 10.4103/0301-4738.49390

Documentation

Similar Products